Marta Gwinn

TL;DR: How pathogen genomics is rapidly evolving and altering public health around the world is explained.

TL;DR: It is suggested that there may be opportunities to exploit samples from trials already completed to investigate possible gene-drug interactions, and to consider the use of the case-only design nested within randomized controlled trials as a possible means of reducing genotyping costs when dichotomous outcomes are being investigated.

TL;DR: Among heterosexual men and women, HIV seroprevalence decreased among whites and, to a lesser degree, Hispanics, but remained essentially stable among African-Americans over time, and among heterosexual IDUs, serop revalence was also unchanged.

TL;DR: Immunologic and virologic results further substantiate the validity of the S/LS EIA strategy for the detection of recent infections and illustrate its use for targeting molecular and epidemiological investigations to incident cases identified from large cross-sectional screening programs, rather than the more costly and logistically difficult longitudinal studies.

TL;DR: Stable seroprevalence among the dynamic population of injection drug users entering treatment suggests continued transmission among these individuals in both high- and low-prevalence areas of the United States.